Search

everythinglearnresearchcommunity

for

Search:↓

Inhibiting Zyxin may help treat androgenetic alopecia by promoting hair growth.

The new hair loss treatment combining nitric oxide and minoxidil in a special carrier is effective for hair regrowth.

A substance from a specific gel helped to grow hair effectively in mice, suggesting it could potentially be used to treat hair loss in humans.

Topical cetirizine 1% increases hair density and may be a promising treatment for hair loss.

PRP treatment improves hair density and thickness for alopecia, but needs more research.

Combining platelet-rich plasma therapy with low dose oral minoxidil improved hair growth in men with hair loss, with slightly higher satisfaction at the higher minoxidil dose.

Different cell types work together to repair skin, and targeting them may improve healing and reduce scarring.

650 nm red light helps hair grow and prevents hair loss by affecting certain genes and biological processes.

Nanomaterials can improve hair care products and treatments, including hair loss and alopecia, by enhancing stability and safety, and allowing controlled release of compounds, but their safety in cosmetics needs more understanding.

Rare genetic variants in five specific genes are linked to male-pattern hair loss but only account for a small part of the risk.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

Platelet-Rich Plasma therapy significantly increases hair density in people with Androgenic Alopecia, and works better with more treatments per month and in younger patients.

Immune activities and specific genes are important in male pattern baldness.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

DNA markers can help predict male pattern baldness, useful in criminal and missing person cases.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Hair follicles in mutant mice self-organize into ordered patterns within a week.

Skin's epithelial stem cells are crucial for repair and maintenance, and understanding them could improve treatments for skin problems.

DNA methylation and long non-coding RNAs are key in controlling hair growth in Cashmere goats.

Hair growth environment recreated with challenges; stem cells make successful skin organoids.

Damage to skin releases dsRNA, which activates TLR3 and helps in skin and hair follicle regeneration.

Ganoderma lucidum extract may help treat stress-related hair loss.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

miR-29a-5p prevents the formation of early hair structures by targeting a gene important for hair growth and is regulated by a complex network involving lncRNA627.1.

ATP-dependent chromatin-remodeling complexes are crucial for gene regulation, cell differentiation, and organ development in mammals.

Activating TLR3 may help produce retinoic acid, important for tissue regeneration.

Melatonin makes cashmere grow earlier and more by increasing certain gene activity in goats.

Topical drugs and near-infrared light therapy show potential for treating alopecia.